Merit Medical Q3 2022 Earnings Report
Key Takeaways
Merit Medical Systems, Inc. reported a 7.5% increase in revenue to $287.2 million for the quarter ended September 30, 2022, with a GAAP EPS of $0.27 and a non-GAAP EPS of $0.64. The company's constant currency revenue, organic, increased by 10.5% compared to the prior year period. They are reaffirming their financial targets outlined in the Foundations for Growth Program.
Reported revenue of $287.2 million, up 7.5% compared to Q3 2021
Constant currency revenue, organic up 10.5% compared to Q3 2021
GAAP operating margin of 6.5%, compared to 6.0% in Q3 2021
Non-GAAP operating margin of 16.1%, compared to 14.8% in Q3 2021
Merit Medical
Merit Medical
Merit Medical Revenue by Segment
Forward Guidance
Merit Medical updated its financial guidance for the year ending December 31, 2022, expecting net sales between $1.145 and $1.151 billion and non-GAAP EPS between $2.55 and $2.61.
Revenue & Expenses
Visualization of income flow from segment revenue to net income